References
- GertzMAImmunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatmentAm J Hematol201388541642523605846
- SmortiMCappelliFBergesioFPerfettoFAnxiety and depression among AL amyloidosis patients: the role of cardiac symptomsAmyloid201219312312822624655
- SeldinDCAndersonJJSanchorawalaVImprovement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantationBlood200410461888189315155460
- CaccialanzaRPalladiniGKlersyCNutritional status independently affects quality of life of patients with systemic immunoglobulin light-chain (AL) amyloidosisAnn Hematol201291339940621826471
- MerliniGPalladiniGLight chain amyloidosis: the heart of the problemHaematologica201398101492149524091927
- LinHMSeldinDHuiABergDDietrichCNFloodEThe patient’s perspective on the symptom and everyday life impact of AL amyloidosisAmyloid201522424425126587688
- WhiteMKBaylissMGuthrieSDRaymondKPRizioAAMcCauslandKLContent validation of the SF-36v2® Health Survey with AL amyloidosis patientsJournal of Patient Reported OutcomesIn press2017
- WareJEJrSF-36 health survey updateSpine200025243130313911124729
- MaruishME webpage on the InternetUser’s Manual for the SF-36v2 Health Survey3rd edLincoln, RIQualityMetric, Inc2011 Available from: https://campaign.optum.com/optum-outcomes.htmlAccessed June 15, 2016
- GuyWNational Institute of Mental Health (US) [webpage on the Internet]Early Clinical Drug Evaluation Program ECDEU Assessment Manual for Psychopharmacology RevRockville, MDU.S. Dept. of Health Education and Welfare Public Health Service Alcohol Drug Abuse and Mental Health Administration National Institute of Mental Health Psychopharmacology Research Branch1976 Available from: http://worldcatlibraries.org/wcpa/oclc/2344751Accessed October 27, 2017
- ReillyMCZbrozekASDukesEMThe validity and reproducibility of a work productivity and activity impairment instrumentPharmacoeconomics19934535336510146874
- SpertusJAJonesPGDevelopment and validation of a short version of the Kansas City Cardiomyopathy QuestionnaireCirc Cardiovasc Qual Outcomes20158546947626307129
- NunnallyJCBernsteinIHPsychometric Theory3rd edNew YorkMcGraw-Hill1994
- ShroutPEFleissJLIntraclass correlations: uses in assessing rater reliabilityPsychol Bull197986242042818839484
- KyleRALinosABeardCMIncidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989Blood1992797181718221558973
- PinneyJHSmithCJTaubeJBSystemic amyloidosis in England: an epidemiological studyBr J Haematol2013161452553223480608
- BoschAMBurlinaACunninghamAAssessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countriesOrphanet J Rare Dis2015108026084935
- HendrikszCJBergerKILampeCHealth-related quality of life in mucopolysaccharidosis: looking beyond biomedical issuesOrphanet J Rare Dis201611111927561270